Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia

New England Journal of Medicine

Volumn 351, Issue 22, 2004, Pages 2276-2285

  Rocha, Vanderson ^a   Labopin, Myriam ^b   Sanz, Guillermo ^c   Arcese, William ^d   Schwerdtfeger, Rainer ^e   Bosi, Alberto ^f   Jacobsen, Niels ^g   Ruutu, Tapani ^h   De Lima, Marcos ⁱ   Finke, Jürgen ^j   Frassoni, Francesco ^k   Gluckman, Eliane ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

^g Rigshospitalet   (Denmark)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j UNIVERSITY OF FREIBURG   (Germany)

^k UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADULT; ARTICLE; BLEEDING; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CARDIOTOXICITY; CAUSE OF DEATH; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; RESPIRATORY DISTRESS SYNDROME; SURVIVAL RATE; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; FETAL BLOOD; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; INCIDENCE; LEUKEMIA; MALE; MIDDLE AGED; NEUTROPHILS; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 9244219607     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa041469     Document Type: Article

References (33)

1. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8.
2. Netcord inventory and use Sept. 2004. (Accessed October 29, 2004, at https://www.netcord.org/inventory.gif.)
3. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
4. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
5. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
6. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
7. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 2000;28:1197-205.
8. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000;342:1846-54.
9. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001;97:2962-71.
10. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cell grafts: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002;8:257-60.
11. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003;101:4233-44.
12. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
13. Sanz GF, Saavedra S, Planelles D, et al. Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies. Blood 2001;98:2332-8.
14. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003;9:772-80.
15. Ooi J, Iseki T, Nagayama H, et al. Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia. Br J Haematol 2001;114:834-6.
16. Ooi J, Iseki T, Takahashi S, et al. Unrelated cord blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004;103:489-91.
17. Sanz G, Rocha V. Umbilical cord blood transplantation: current status and future directions. Curr Opin Organ Transplant 2003;8:109-17.
18. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295-304.
19. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-17.
20. Gooley TA, Leisenring W, Crowley JA, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:665-706.
21. Fine JP, Gray RJ. A proportional hazards model for subdisttibution of a competing risk. J Am Stat Assoc 1999;94:496-509.
22. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcome of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004;32:397-407.
23. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-8.
24. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001;97:2957-61.
25. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993;178:787-91.
26. Frassoni F, Podesta M, Maccario R, et al. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 2003;102:1138-41.
27. Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994;154:14-24.
28. Madrigal JA, Cohen SB, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. Hum Immunol 1997;56:1-5.
29. Lewis ID, Almeida-Porara G, Du J, et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood 2001;97:3441-9.
30. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998;338:962-8.
31. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and the recipient. Blood 1998;92:3515-20.
32. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med 1998;339:1177-85. [Erratum, N Engl J Med 1999;340:402.]
33. Klein AK, Patel DD, Gooding ME, et al. T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001;7:454-66.